Regarding health issues caused by Kobayashi Pharmaceutical's health products containing red yeast, the Japan Consumer Affairs Agency held the second meeting of the “Expert Seminar” on the establishment of a functional labeling food system on the 24th local time, and listened to the opinions of consumer groups. Consumer groups said that the current system cannot ensure safety and called for strict rules to guarantee the safety and quality of health products.
小林制药保健品引争议，日本研讨加强安全制度
Kobayashi Pharmaceutical health products cause controversy, Japan discusses strengthening safety systems
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.